+ All Categories
Home > Documents > Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70....

Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70....

Date post: 21-Apr-2020
Category:
Upload: others
View: 2 times
Download: 0 times
Share this document with a friend
17
z Medical Management of Coronary Artery Disease Joe Chavez, M.D.
Transcript
Page 1: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

Medical Management of Coronary Artery

DiseaseJoe Chavez, M.D.

Page 2: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

Disclosures

I have no disclosures or conflicts to report

Page 3: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

What does CAD look like?

Acute events: STEMI, Unstable Angina

PCI, Stents, Hospitalization

Dual antiplatelet therapy

IABP, Impella

CABG

Page 4: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

What does CAD look like?

Chronic

Symptoms: angina, dyspnea, fatigue

Triggers: exertion, eating

Enablers: BP, lung disease, anemia, catecholamines

Confounders: obesity, sedentary lifestyle

Timing: exertional, non-exertional; frequency

Page 5: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

Approach to Therapy

What are we treating?

-Myocardial oxygen supply and demand

factors: BP, HR, weight, activity

Has anything changed?

-Home, work, travel

Page 6: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

Medical Therapy

Beta Blockers

Metoprolol, Carvedilol, Atenolol, Propranolol

Adjust based on BP, HR, LVEF

Other medical needs: migraine, tremor, kidney disease

Page 7: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

Medical Therapy

ACEI and ARB

No incremental benefit of ARB over ACEI

Tailoring: kidney disease

Page 8: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

Medical Therapy

Antiplatelet therapy: Aspirin 81mg; no benefit to chronic dose of

325mg; Patients on Ticagrelor

Statin therapy High Potency – Atorvastatin, Rosuvastatin

PCSK9 inhibitors: statin intolerant or non-responsive

Page 9: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

Medical Therapy

Nitrates: only for symptoms; may be useful in some patients, prior

to established trigger for angina

Page 10: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

CCB

No evidence of benefit, except for symptoms and as add-on.

Contraindicated in CHF, reduced LVEF (Diltiazem, Verapamil)

Page 11: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

Patient AA

He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol

2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75.

He reports angina at a half mile walk. Walks daily, about 2-3

miles. He had 3 vessel CABG 10 years ago; LIMA was not

suitable for grafting. Subsequent cardiac cath, for symptoms,

showed diffuse graft disease and native disease. No targets for

revascularization.

Page 12: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

Patient AA continued

What next:

-Lower LDL

-Increase beta blockade

-Nitrates

Page 13: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

Patient TS

65 yo woman. CAD: previous PCI/stent to LAD. LVEF 60%. DM,

HTN, HLD, Sedentary, BMI 38, BP 130/80

Recurrent chest pain on minimal exertion and sometimes after

meals. Better with nitrates.

Multiple ED visits and admits.

Negative stress tests.

Cardiac catheterization – no obstruction

Page 14: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

70 yo man with recurrent exertional chest pain, HTN, HLD

Echo: LVEF 45%

Beta blocker, ACEI, Aspirin

Despite maximum tolerated medications continued to have frequent

angina

Cardiac catheterization: proximal 3 vessel CAD

Patient BT

Page 15: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

Patient BT continued

CABG recommended. Patient declined.

Later developed atrial fibrillation. Medications modified.

Lived > 5 years post cardiac catheterization.

Page 16: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

Stress testing

Exercise is better than pharmacologic if possible

Patients with LBBB or pacing: no treadmill if looking for

ischemia.

Page 17: Medical Management of Coronary Artery Disease · z Patient AA He is 75 yo. BMI 25, BP 110/70. Atorvastatin 80mg, Nebivolol 2.5mg, Lisinopril 2.5mg, Aspirin 81mg. LDL 75. He reports

z

Conclusions:

Medical therapy: beta blockers, ACEI/ARB, Antiplatelet agents,

anti-lipidemic therapy

Nitrates for symptoms

Treat co-disease states: DM, obesity, sedentary status

CAD is a chronic process

A cardiac catheterization is not for everyone

Many patients will do well on OMT alone (ISCHEMIA trial)


Recommended